Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia (MK-7655A-016)
Clinical trial NCT03583333 · COMPLETED
Trial details
- NCT number
- NCT03583333
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-18
- Primary completion
- 2022-07-12
- Enrollment
- 274
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.